Does METOPROLOL Cause Product solubility abnormal? 39 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Product solubility abnormal have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.1% of all adverse event reports for METOPROLOL.
39
Reports of Product solubility abnormal with METOPROLOL
0.1%
of all METOPROLOL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product solubility abnormal From METOPROLOL?
Of the 39 reports, 1 (2.6%) required hospitalization.
Is Product solubility abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Product solubility abnormal?
BUPRENORPHINE (498)
BUPRENORPHINE\NALOXONE (274)
POLYETHYLENE GLYCOL 3350 (220)
CHOLESTYRAMINE (193)
PATIROMER (107)
LEVOTHYROXINE (100)
SOMATROPIN (98)
EXENATIDE (97)
ESTRADIOL (94)
NITROGLYCERIN (81)
Which METOPROLOL Alternatives Have Lower Product solubility abnormal Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE